-
1
-
-
77955741321
-
Effects of T cell-induced colonic inflammation on epithelial barrier function
-
Suenaert P, Maerten P, Van Assche G et al. Effects of T cell-induced colonic inflammation on epithelial barrier function. Inflamm Bowel Dis 2010; 16:1322-31.
-
(2010)
Inflamm Bowel Dis
, vol.16
, pp. 1322-1331
-
-
Suenaert, P.1
Maerten, P.2
Van Assche, G.3
-
2
-
-
84878258216
-
Supplemental naringenin prevents intestinal barrier defects and inflammation in colitic mice
-
Azuma T, Shigeshiro M, Kodama M Tanabe S, Suzuki T. Supplemental naringenin prevents intestinal barrier defects and inflammation in colitic mice. J Nutr 2013; 143:827-34.
-
(2013)
J Nutr
, vol.143
, pp. 827-834
-
-
Azuma, T.1
Shigeshiro, M.2
Kodama, M.3
Tanabe, S.4
Suzuki, T.5
-
3
-
-
84876404920
-
Increased epithelial permeability is the primary cause for bicarbonate loss in inflamed murine colon
-
Juric M, Xiao F, Amasheh S et al. Increased epithelial permeability is the primary cause for bicarbonate loss in inflamed murine colon. Inflamm Bowel Dis 2013; 19:904-11.
-
(2013)
Inflamm Bowel Dis
, vol.19
, pp. 904-911
-
-
Juric, M.1
Xiao, F.2
Amasheh, S.3
-
4
-
-
84881030277
-
Complex roles of caspases in the pathogenesis of inflammatory bowel disease
-
Becker C, Watson AJ, Neurath MF. Complex roles of caspases in the pathogenesis of inflammatory bowel disease. Gastroenterology 2013; 144:283-93.
-
(2013)
Gastroenterology
, vol.144
, pp. 283-293
-
-
Becker, C.1
Watson, A.J.2
Neurath, M.F.3
-
5
-
-
85028094075
-
Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease
-
Schumann M, Gunzel D, Buergel N et al. Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease. Gut 2012; 61:220-8.
-
(2012)
Gut
, vol.61
, pp. 220-228
-
-
Schumann, M.1
Gunzel, D.2
Buergel, N.3
-
6
-
-
84880611949
-
TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis
-
Su L, Nalle SC, Shen L et al. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology 2013; 145:407-15.
-
(2013)
Gastroenterology
, vol.145
, pp. 407-415
-
-
Su, L.1
Nalle, S.C.2
Shen, L.3
-
7
-
-
0027521572
-
Interleukin-10-deficient mice develop chronic enterocolitis
-
Kuhn R, Lohler J, Rennick D Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263-74.
-
(1993)
Cell
, vol.75
, pp. 263-274
-
-
Kuhn, R.1
Lohler, J.2
Rennick, D.3
Rajewsky, K.4
Muller, W.5
-
8
-
-
84879195829
-
Iron status, anemia, and plasma erythropoietin levels in acute and chronic mouse models of colitis
-
Carter PR, Watts MN, Kosloski-Davidson M, Prasai K, Grisham MB, Harris NR. Iron status, anemia, and plasma erythropoietin levels in acute and chronic mouse models of colitis. Inflamm Bowel Dis 2013; 19:1260-5.
-
(2013)
Inflamm Bowel Dis
, vol.19
, pp. 1260-1265
-
-
Carter, P.R.1
Watts, M.N.2
Kosloski-Davidson, M.3
Prasai, K.4
Grisham, M.B.5
Harris, N.R.6
-
9
-
-
83555172379
-
The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease
-
Wang L, Trebicka E, Fu Y et al. The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18:112-9.
-
(2012)
Inflamm Bowel Dis
, vol.18
, pp. 112-119
-
-
Wang, L.1
Trebicka, E.2
Fu, Y.3
-
10
-
-
84879805222
-
Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis
-
Yin H, Li X, Zhang B, et al. Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis. Immunology 2013; 139:494-502.
-
(2013)
Immunology
, vol.139
, pp. 494-502
-
-
Yin, H.1
Li, X.2
Zhang, B.3
-
11
-
-
84891894115
-
TRAIL receptor deficiency sensitizes mice to dextran sodium sulphate-induced colitis and colitis-associated carcinogenesis
-
Zhu J, Chen L, Shi J, Liu S, Liu Y Zheng D. TRAIL receptor deficiency sensitizes mice to dextran sodium sulphate-induced colitis and colitis-associated carcinogenesis. Immunology 2014; 141:211-21.
-
(2014)
Immunology
, vol.141
, pp. 211-221
-
-
Zhu, J.1
Chen, L.2
Shi, J.3
Liu, S.4
Liu, Y.5
Zheng, D.6
-
12
-
-
78650505681
-
KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production
-
Goettel JA, Scott AHM, Olivares-Villagomez D et al. KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production. Gastroenterology 2011; 140:265-74.
-
(2011)
Gastroenterology
, vol.140
, pp. 265-274
-
-
Goettel, J.A.1
Scott, A.H.M.2
Olivares-Villagomez, D.3
-
13
-
-
84899580331
-
Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice
-
de Chambrun GP, Body-Malapel M Frey-Wagner I et al. Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice. Mucosal Immunol 2014; 7:589-601.
-
(2014)
Mucosal Immunol
, vol.7
, pp. 589-601
-
-
de Chambrun, G.P.1
Body-Malapel, M.2
Frey-Wagner, I.3
-
14
-
-
84855672962
-
New pathogenic paradigms in inflammatory bowel disease
-
Di SA, Biancheri P, Rovedatti L MacDonald TT, Corazza GR. New pathogenic paradigms in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18:368-71.
-
(2012)
Inflamm Bowel Dis
, vol.18
, pp. 368-371
-
-
Di, S.A.1
Biancheri, P.2
Rovedatti, L.3
MacDonald, T.T.4
Corazza, G.R.5
-
16
-
-
68849084141
-
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)
-
Jones JL, Phuah CL, Cox AL et al. IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H). J Clin Invest 2009; 119:2052-61.
-
(2009)
J Clin Invest
, vol.119
, pp. 2052-2061
-
-
Jones, J.L.1
Phuah, C.L.2
Cox, A.L.3
-
17
-
-
84862677418
-
Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis
-
Rao SP, Sancho J, Campos-Rivera J et al. Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis. PLoS One 2012; 7:e39416.
-
(2012)
PLoS One
, vol.7
, pp. e39416
-
-
Rao, S.P.1
Sancho, J.2
Campos-Rivera, J.3
-
18
-
-
84862908724
-
Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia
-
Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Wu CO, Young NS. Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia. Blood 2012; 119:345-54.
-
(2012)
Blood
, vol.119
, pp. 345-354
-
-
Scheinberg, P.1
Nunez, O.2
Weinstein, B.3
Scheinberg, P.4
Wu, C.O.5
Young, N.S.6
-
19
-
-
84869507357
-
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
-
Coles AJ, Twyman CL, Arnold DL et al. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet 2012; 380:1829-39.
-
(2012)
Lancet
, vol.380
, pp. 1829-1839
-
-
Coles, A.J.1
Twyman, C.L.2
Arnold, D.L.3
-
20
-
-
84869492471
-
Alemtuzumab versus interferon β1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
-
Cohen JA, Coles AJ, Arnold DL et al. Alemtuzumab versus interferon β1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet 2012; 380:1819-28.
-
(2012)
Lancet
, vol.380
, pp. 1819-1828
-
-
Cohen, J.A.1
Coles, A.J.2
Arnold, D.L.3
-
21
-
-
79958863377
-
Antimouse CD52 monoclonal antibody inhibits established spontaneous colitis in IL-10-deficient mice
-
Zhu WM, Li Y, Yu C, Li N, Li JS. Antimouse CD52 monoclonal antibody inhibits established spontaneous colitis in IL-10-deficient mice. Inflamm Bowel Dis 2011; 17:E72-3.
-
(2011)
Inflamm Bowel Dis
, vol.17
, pp. E72-E73
-
-
Zhu, W.M.1
Li, Y.2
Yu, C.3
Li, N.4
Li, J.S.5
-
22
-
-
84899689659
-
Anti-mouse CD52 monoclonal antibody ameliorates iron-deficient anaemia in IL-10 knockout mice
-
Wang H, Dong J, Zuo L et al. Anti-mouse CD52 monoclonal antibody ameliorates iron-deficient anaemia in IL-10 knockout mice. Br J Nutr 2014; 111:987-95.
-
(2014)
Br J Nutr
, vol.111
, pp. 987-995
-
-
Wang, H.1
Dong, J.2
Zuo, L.3
-
23
-
-
7244248661
-
Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice
-
Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF Jr, Weinstock JV. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 2004; 34:2690-8.
-
(2004)
Eur J Immunol
, vol.34
, pp. 2690-2698
-
-
Elliott, D.E.1
Setiawan, T.2
Metwali, A.3
Blum, A.4
Urban, J.F.5
Weinstock, J.V.6
-
25
-
-
79960919901
-
Control of TH17 cells occurs in the small intestine
-
Esplugues E, Huber S, Gagliani N et al. Control of TH17 cells occurs in the small intestine. Nature 2011; 475:514-8.
-
(2011)
Nature
, vol.475
, pp. 514-518
-
-
Esplugues, E.1
Huber, S.2
Gagliani, N.3
-
26
-
-
79955076206
-
Estrogen receptor-β signaling modulates epithelial barrier function
-
Looijer-van LM, Hotte N, Dieleman LA, Albert E, Mulder C, Madsen KL. Estrogen receptor-β signaling modulates epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 2011; 300:G621-6.
-
(2011)
Am J Physiol Gastrointest Liver Physiol
, vol.300
, pp. G621-G626
-
-
Looijer-van, L.M.1
Hotte, N.2
Dieleman, L.A.3
Albert, E.4
Mulder, C.5
Madsen, K.L.6
-
27
-
-
84877970588
-
Bifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injury
-
Wang H, Zhang W, Zuo L et al. Bifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injury. Br J Nutr 2013; 109:1990-8.
-
(2013)
Br J Nutr
, vol.109
, pp. 1990-1998
-
-
Wang, H.1
Zhang, W.2
Zuo, L.3
-
28
-
-
80051926938
-
Epithelial inducible nitric oxide synthase causes bacterial translocation by impairment of enterocytic tight junctions via intracellular signals of Rho-associated kinase and protein kinase C ζ
-
Wu LL, Chiu HD, Peng WH et al. Epithelial inducible nitric oxide synthase causes bacterial translocation by impairment of enterocytic tight junctions via intracellular signals of Rho-associated kinase and protein kinase C ζ. Crit Care Med 2011; 39:2087-98.
-
(2011)
Crit Care Med
, vol.39
, pp. 2087-2098
-
-
Wu, L.L.1
Chiu, H.D.2
Peng, W.H.3
-
29
-
-
84896042427
-
Intestinal dysbacteriosis contributes to decreased intestinal mucosal barrier function and increased bacterial translocation
-
Wang H, Zhang W, Zuo L et al. Intestinal dysbacteriosis contributes to decreased intestinal mucosal barrier function and increased bacterial translocation. Lett Appl Microbiol 2014; 58:384-92.
-
(2014)
Lett Appl Microbiol
, vol.58
, pp. 384-392
-
-
Wang, H.1
Zhang, W.2
Zuo, L.3
-
30
-
-
79958277385
-
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease
-
Geremia A, Arancibia-Carcamo CV, Fleming MP et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 2011; 208:1127-33.
-
(2011)
J Exp Med
, vol.208
, pp. 1127-1133
-
-
Geremia, A.1
Arancibia-Carcamo, C.V.2
Fleming, M.P.3
-
31
-
-
70049093126
-
Translating inflammatory bowel disease research into clinical medicine
-
Neurath MF, Finotto S. Translating inflammatory bowel disease research into clinical medicine. Immunity 2009; 31:357-61.
-
(2009)
Immunity
, vol.31
, pp. 357-361
-
-
Neurath, M.F.1
Finotto, S.2
-
32
-
-
77950588683
-
Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity
-
Weber CR, Raleigh DR, Su L et al. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem 2010; 285:12037-46.
-
(2010)
J Biol Chem
, vol.285
, pp. 12037-12046
-
-
Weber, C.R.1
Raleigh, D.R.2
Su, L.3
-
33
-
-
53749106751
-
The suppressive effect of triptolide on chronic colitis and TNF-α/TNFR2 signal pathway in interleukin-10 deficient mice
-
Wei X, Gong J, Zhu J et al. The suppressive effect of triptolide on chronic colitis and TNF-α/TNFR2 signal pathway in interleukin-10 deficient mice. Clin Immunol 2008; 129:211-8.
-
(2008)
Clin Immunol
, vol.129
, pp. 211-218
-
-
Wei, X.1
Gong, J.2
Zhu, J.3
-
34
-
-
84904242872
-
Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice
-
Dong J, Wang H, Wu G et al. Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice. Clin Exp Immunol 2014; 177:94-101.
-
(2014)
Clin Exp Immunol
, vol.177
, pp. 94-101
-
-
Dong, J.1
Wang, H.2
Wu, G.3
-
36
-
-
79959271087
-
Intestinal homeostasis and its breakdown in inflammatory bowel disease
-
Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474:298-306.
-
(2011)
Nature
, vol.474
, pp. 298-306
-
-
Maloy, K.J.1
Powrie, F.2
-
37
-
-
24144465134
-
Epithelial barrier function in vivo is sustained despite gaps in epithelial layers
-
Watson AJ, Chu S, Sieck L et al. Epithelial barrier function in vivo is sustained despite gaps in epithelial layers. Gastroenterology 2005; 129:902-12.
-
(2005)
Gastroenterology
, vol.129
, pp. 902-912
-
-
Watson, A.J.1
Chu, S.2
Sieck, L.3
-
38
-
-
84880026950
-
Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF
-
Vandenbroucke RE, Dejonckheere E, Van Hauwermeiren F et al. Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF. EMBO Mol Med 2013; 5:1000-16.
-
(2013)
EMBO Mol Med
, vol.5
, pp. 1000-1016
-
-
Vandenbroucke, R.E.1
Dejonckheere, E.2
Van Hauwermeiren, F.3
-
39
-
-
73949105149
-
Epithelial NF-κB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation
-
Tang Y, Clayburgh DR, Mittal N et al. Epithelial NF-κB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation. Am J Pathol 2010; 176:158-67.
-
(2010)
Am J Pathol
, vol.176
, pp. 158-167
-
-
Tang, Y.1
Clayburgh, D.R.2
Mittal, N.3
-
40
-
-
84857682579
-
Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics
-
Hering NA, Fromm M, Schulzke JD. Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. J Physiol 2012; 590:1035-44.
-
(2012)
J Physiol
, vol.590
, pp. 1035-1044
-
-
Hering, N.A.1
Fromm, M.2
Schulzke, J.D.3
-
41
-
-
33845995125
-
Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease
-
Zeissig S, Burgel N, Gunzel D et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007; 56:61-72.
-
(2007)
Gut
, vol.56
, pp. 61-72
-
-
Zeissig, S.1
Burgel, N.2
Gunzel, D.3
-
42
-
-
84897985897
-
Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation
-
Vivinus-Nebot M, Frin-Mathy G, Bzioueche H et al. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut 2014; 63:744-52.
-
(2014)
Gut
, vol.63
, pp. 744-752
-
-
Vivinus-Nebot, M.1
Frin-Mathy, G.2
Bzioueche, H.3
-
43
-
-
84878667737
-
Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells
-
Fischer A, Gluth M, Pape UF, Wiedenmann B, Theuring F, Baumgart DC. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2013; 304:G970-9.
-
(2013)
Am J Physiol Gastrointest Liver Physiol
, vol.304
, pp. G970-G979
-
-
Fischer, A.1
Gluth, M.2
Pape, U.F.3
Wiedenmann, B.4
Theuring, F.5
Baumgart, D.C.6
-
44
-
-
80054716832
-
Increase in the tight junction protein claudin-1 in intestinal inflammation
-
Poritz LS, Harris LR 3rd, Kelly AA, Koltun WA. Increase in the tight junction protein claudin-1 in intestinal inflammation. Dig Dis Sci 2011; 56:2802-9.
-
(2011)
Dig Dis Sci
, vol.56
, pp. 2802-2809
-
-
Poritz, L.S.1
Harris 3rd, L.R.2
Kelly, A.A.3
Koltun, W.A.4
-
45
-
-
30944443377
-
Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease
-
Blair SA, Kane SV, Clayburgh DR, Turner JR. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest 2006; 86:191-201.
-
(2006)
Lab Invest
, vol.86
, pp. 191-201
-
-
Blair, S.A.1
Kane, S.V.2
Clayburgh, D.R.3
Turner, J.R.4
-
46
-
-
33749466490
-
IFN-γ-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction
-
Wang F, Schwarz BT, Graham WV et al. IFN-γ-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 2006; 131:1153-63.
-
(2006)
Gastroenterology
, vol.131
, pp. 1153-1163
-
-
Wang, F.1
Schwarz, B.T.2
Graham, W.V.3
-
47
-
-
19144364861
-
Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes
-
Waschke KA, Villani AC, Vermeire S et al. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes. Am J Gastroenterol 2005; 100:1126-33.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1126-1133
-
-
Waschke, K.A.1
Villani, A.C.2
Vermeire, S.3
|